Recent Updates
Recently added Catalysts
MLSS Positive Sentiment

Loss-of-Resistance Versus Dynamic Pressure-Sensing Technology for Successful Placement of Thoracic Epidural Catheters: A Randomized Clinical Trial

Key Takeaway: The article discusses a randomized clinical trial comparing loss-of-resistance and dynamic pressure-sensing technology for the placement of thoracic epidural catheters. The trial aims to evaluate the effectiveness and safety of these methods. Preliminary results suggest positive outcomes for the dynamic pressure-sensing approach, highlighting its potential in clinical practice.
Price reaction · baseline $0.6599 (2024-07-01T16:15:00.000Z) · hit during market hours · clean, no other MLSS news in the window
day 0 close · peak
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Successful placement of thoracic epidural catheters using new technology.
  • Clinical trial demonstrates potential benefits of dynamic pressure-sensing.
  • Growing clinical adoption indicates increasing physician acceptance.

Full Press Release Details

• SHARE

Read the full publication here .

LATEST NEWS

• Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9%… July 1, 2026
• Milestone Scientific Strengthens Board to Support Next Phase of Growth June 25, 2026
• Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance… May 27, 2026

Frequently Asked Questions

What was the focus of the clinical trial?

The trial focused on comparing loss-of-resistance and dynamic pressure-sensing technology for thoracic epidural catheter placement.

What technology showed promising results?

Dynamic pressure-sensing technology demonstrated positive outcomes in the trial.

What does the trial indicate about physician acceptance?

The trial highlights growing clinical adoption and expanding physician acceptance of the new technology.

When were the preliminary results reported?

Preliminary results were reported in the context of the trial's findings.

Last updated: Jul 1, 2024